Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the
Europe Advanced Wound Care Market
Request Now !
Advanced wound care consists of products that is used to heal acute or chronic wounds. Advanced wound care products work by regulating adequate oxygen flow and maintaining required temperature around the wound. Further, it provides protection against bacterial & microbial infection, thereby reducing complications.
Increasing cases of patients with diabetes, rise in aging population, and faulty lifestyle are factors that foster growth of the Europe advanced wound care market. However, high cost involved in treatment is a key factor that would restrain the growth of the market across Europe. Rising demand of active wound care products especially in emerging nations are expected to create abundant growth opportunities in this market.
The report segments the Europe advanced wound care market on the basis of application, method, end-user and country. Based on application, this market is segmented into surgical wounds, ulcers, and other wounds, where ulcers are further segmented into diabetic foot ulcers, venous ulcers, pressure ulcers, and arterial ulcers. The method segment includes dressings and grafts, in which dressings segment is further segmented into antimicrobial dressings, foam dressings, gauze, hydrocolloids collagen, film dressings, hydrogels, composites, alginate dressings; and grafts are further segmented into composite skin grafts and biologic grafts. Biologic grafts segments include autografts, allografts and xenografts. On the basis of end-users, the market is segmented into inpatient and outpatient facilities. On the basis of country, the market is segmented into Germany, U.K., Italy, France, Spain, and Rest of Europe (RoE).
Prominent market players operating in this market are Smith and Nephew, PLC. Integra Life Sciences Corporation, Molyncke Health Care, Convatec, Inc., Coloplast Group, Organogenesis, Inc., Medline Industries, Inc., Shire, PLC., Mimedx Group, Inc., Laboratories Urgo and Systagenix.
- The report provides a comprehensive analysis of current & future market trends and emerging avenues for the growth of this market.
- The report offers an overview of changing market dynamics in terms of fast turn-around analysis of stakeholders responses to recent industry policy changes and market trends.
- The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
- This report entails the detailed quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.
- Recent developments in government policies on various segments is highlighted along with offering insight into the regulatory framework impacting the market.
- The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
- The report offers the competitive landscape scenario in terms of the strategies adopted by key industry players to consolidate their market presence.
Europe Advanced Wound Care Market Key Segments:
- Surgical Wounds
- Diabetic Foot Ulcers
- Venous Ulcers
- Pressure Ulcers
- Arterial Ulcers
- Other Wounds
- Antimicrobial Dressings
- Foam Dressings
- Hydrocolloids Collagen
- Film Dressings
- Alginate Dressings
- Composite Skin Grafts
- Biologic Grafts
- Outpatient Facilities
- Rest of Europe (RoE)
Key Company Profile
- Smith and Nephew, PLC.
- Integra Life Sciences Corporation
- Molyncke Health Care
- Convatec, Inc.
- Coloplast Group
- Organogenesis, Inc.
- Medline Industries, Inc.
- Shire, PLC.
- Mimedx Group, Inc.
- Laboratories Urgo and Systagenix.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
CHAPTER 4 EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT
4.1.1. Market size and forecast
4.2. INFECTION MANAGEMENT
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Silver wound dressings
184.108.40.206. Market size and forecast
4.2.5. Non silver dressings
220.127.116.11. Market size and forecast
4.2.6. Collagen dressings
18.104.22.168. Market size and forecast
4.3. EXUDATE MANAGEMENT
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Hydrocolloids dressings
22.214.171.124. Market size and forecast
4.3.5. Foam dressings
126.96.36.199. Market size and forecast
4.3.6. Alginate dressings
188.8.131.52. Market size and forecast
4.3.7. Hydrogels dressings
184.108.40.206. Market size and forecast
4.4. ACTIVE WOUND CARE
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Skin substitutes
220.127.116.11. Market size and forecast
4.4.5. Growth factors
18.104.22.168. Market size and forecast
4.5. THERAPY DEVICES
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Negative pressure wound therapy
22.214.171.124. Market size and forecast
4.5.5. Oxygen and hyperbaric oxygen equipments
126.96.36.199. Market size and forecast
4.5.6. Electromagnetic therapy devices
188.8.131.52. Market size and forecast
184.108.40.206. Market size and forecast
CHAPTER 5 EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2. CHRONIC WOUNDS
5.2.1. Market size and forecast
5.2.2. Pressure ulcers
220.127.116.11. Market size and forecast
5.2.3. Diabetic foot ulcers
18.104.22.168. Market size and forecast
5.2.4. Venous leg ulcers
22.214.171.124. Market size and forecast
5.2.5. Arterial ulcers
126.96.36.199. Market size and forecast
5.3. ACUTE WOUNDS
5.3.1. Market size and forecast
5.3.2. Burns and trauma
188.8.131.52. Market size and forecast
5.3.3. Surgical wounds
184.108.40.206. Market size and forecast
CHAPTER 6 EUROPE ADVANCED WOUND CARE MARKET, BY END USER
6.1.1. Market size and forecast
6.2.1. Market size and forecast
6.3. COMMUNITY HEALTH SERVICE CENTERS
6.3.1. Market size and forecast
CHAPTER 7 EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY
7.1.1. Key market trends
7.1.2. Key growth factors and opportunities
7.1.3. Market size and forecast
220.127.116.11. Germany market size and forecast
18.104.22.168. France market size and forecast
22.214.171.124. UK market size and forecast
126.96.36.199. Italy market size and forecast
188.8.131.52. Spain market size and forecast
184.108.40.206. Rest of Europe market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. SMITHS GROUP PLC
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. ALLIQUA BIOMEDICAL, INC.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. MÖLNLYCKE HEALTH CARE AB
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. MEDTRONIC PLC
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. ACELITY L.P. INC.
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. CONVATEC HEALTHCARE B S.À.R.L.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. BSN MEDICAL GMBH
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. 3M COMPANY
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. SRS MEDICAL SYSTEMS, INC.
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments